COATS'S DISEASE: II. STUDIES ON THE IDENTITY OF THE LIPIDS CONCERNED, AND THE PROBABLE ROLE OF MUCOPOLYSACCHARIDES IN ITS PATHOGENESIS

. 1963 Jul;47(7):413–434. doi: 10.1136/bjo.47.7.413

COATS'S DISEASE^{^*}

II. STUDIES ON THE IDENTITY OF THE LIPIDS CONCERNED, AND THE PROBABLE ROLE OF MUCOPOLYSACCHARIDES IN ITS PATHOGENESIS^†

PMCID: PMC505827 PMID: 14189711

These references are in PubMed. This may not be the complete list of references from this article.

BRAGDON J. H., HAVEL R. J. In vivo effect of anti-heparin agents on serum lipids and lepoproteins. Am J Physiol. 1954 Apr;177(1):128–133. doi: 10.1152/ajplegacy.1954.177.1.128. [DOI] [PubMed] [Google Scholar]
KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955 Jul;215(1):1–14. [PubMed] [Google Scholar]
WOODS A. C., DUKE J. R. COATS'S DISEASE. I. REVIEW OF THE LITERATURE, DIAGNOSTIC CRITERIA, CLINICAL FINDINGS, AND PLASMA LIPID STUDIES. Br J Ophthalmol. 1963 Jul;47:385–412. doi: 10.1136/bjo.47.7.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
ZIMMERMAN L. E. Demonstration of hyaluronidase-sensitive acid mucopolysaccharide in trabecula and iris in routine paraffin sections of adult human eyes; a preliminary report. Am J Ophthalmol. 1957 Jul;44(1):1–4. [PubMed] [Google Scholar]